Aspirin Protects Endothelial Cells From Oxidant Damage Via the Nitric Oxide-cGMP Pathway
- 1 August 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (8) , 1345-1351
- https://doi.org/10.1161/01.atv.0000083296.57581.ae
Abstract
Objectives— Aspirin is known to exert cytoprotection by presently unidentified mechanisms. This study investigates the involvement of nitric oxide (NO) in antioxidant cellular protection induced by...Keywords
This publication has 42 references indexed in Scilit:
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Effects of low‐dose aspirin on endothelial function in hypertensive patientsClinical Cardiology, 2001
- Cyclooxygenase‐independent actions of cyclooxygenase inhibitorsThe FASEB Journal, 2001
- A Common Pathway for Nitric Oxide Release from NO–Aspirin and Glyceryl TrinitrateBiochemical and Biophysical Research Communications, 2000
- Cyclic AMP Mediates Endothelial Protection by Nitric OxideBiochemical and Biophysical Research Communications, 1998
- Inhibition of NF-κB by Sodium Salicylate and AspirinScience, 1994
- Antioxidant characteristics of some potential anticataract agentsFree Radical Biology & Medicine, 1990
- Aspirin in Cardiovascular DiseaseDrugs, 1988
- The iron-binding and hydroxyl radical scavenging action of anti-inflammatory drugsXenobiotica, 1988
- ProstaglandinsAnnual Review of Biochemistry, 1975